GlassScriptPhysician profile
Debora V Whitehurst Brown
NPI 1427120922
$1,508.81
in general payments reported to CMS, 2019-2025
24 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $417 · 2020: $116 · 2021: $113 · 2022: $243 · 2023: $41.74 · 2024: $466 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $303.88 | 2024-2025 | Veozah |
| Therapeuticsmd, INC. | $249.45 | 2019 | |
| Abbvie INC. | $140.96 | 2019-2022 | |
| Acessa Health INC. | $112.68 | 2022 | |
| Gilead Sciences, INC. | $92.58 | 2020 | |
| Hologic Sales and Service, LLC | $85.90 | 2024 | Acessa Provu System |
| Myovant Sciences INC. | $81.81 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $65.76 | 2023-2024 | Myfembree |
| Sage Therapeutics, LLC | $45.05 | 2021-2022 | |
| Organon LLC | $39.16 | 2021-2024 | |
| Smith+Nephew, INC. | $38.98 | 2021-2024 | Pico 7 |
| Daiichi Sankyo INC. | $35.17 | 2019 | |
| Exeltis, USA INC. | $34.04 | 2024 | Slynd |
| Conmed Corporation | $26.32 | 2025 | Airseal |
| Mayne Pharma Commercial LLC | $23.17 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $19.17 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Meditrina | $17.03 | 2025 | |
| Merck Sharp & Dohme LLC | $16.33 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.31 | 2021 | |
| Evofem Biosciences, INC. | $14.47 | 2022 | |
| Coopersurgical, INC. | $14.25 | 2019 | |
| Avion Pharmaceuticals | $14.13 | 2019 | |
| Duchesnay USA Incorporated | $11.82 | 2019 | |
| Lupin INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debora Whitehurst Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.